Optimized radioiodine therapy for graves' disease: two mird-based models for the computation of patient-specific therapeutic i activity

Nuclear Medicine Communications

Volumn 27, Issue 7, 2006, Pages 559-566

  Carlier, Thomas ^a   Salaun, Pierre Yves ^a   Cavarec, Marie Béatrice ^b   Valette, Frédéric ^b   Turzo, Alexandre ^b   Bardiès, Manuel ^b   Bizais, Yves ^c   Couturier, Olivier ^c  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c BREST UNIVERSITY HOSPITAL   (France)

Author keywords

Graves' disease; MIRD based models; Therapy

Indexed keywords

IODINE 123;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSIMETRY; DRUG ACTIVITY; DRUG HALF LIFE; DRUG UPTAKE; FEMALE; GRAVES DISEASE; HUMAN; MALE; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; STATISTICAL SIGNIFICANCE; THYROID MASS;

BODY BURDEN; COMPUTER SIMULATION; FEMALE; FRANCE; GRAVES DISEASE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; QUALITY ASSURANCE, HEALTH CARE; RADIOMETRY; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, COMPUTER-ASSISTED; RELATIVE BIOLOGICAL EFFECTIVENESS; TREATMENT OUTCOME;

EID: 33748123942     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200607000-00003     Document Type: Article

References (30)

1. Leslie WD, Ward L, Salamon EA, Ludwig S, Rowe RC, Cowden EA. A randomized comparison of radioiodine doses in Graves' hyperthyroidism. J Clinical Endoc Metabol 2003; 88:978-983.
2. Catargi B, Leprat F, Guyot M, Valli N, Ducassou D, Tabarin A, et al. Optimized radioiodine therapy of Graves' disease: analysis of the delivered dose and other possible factors affecting outcome. Eur J Endocrinol 1999; 141:117-121.
3. Allahabadia A, Daykin J, Sheppard MC, Gough SCL, Franklyn JA. Radioiodine treatment of hyperthyroidism. Prognostic factors for outcome. J Clin Endocrinol Metabol 2001; 86:3611-3617.
4. Kaplan MM, Meier DA, Dworkin HJ. Treatment of hyperthyroidism with radioactive iodine. Endocrinol Metab Clin North Am 1998; 27:205-223.
5. Franklyn JA, Daykin J, Drolc Z, Farmer M, Sheppard MC. Long-term follow-up of treatment of thyrotoxicosis by three different methods. Clin Endocrinol 1991; 34:71-76.
6. Hennemann G, Krenning EP, Sankaranarayanan K. Place of radioactive iodine in treatment of thyrotoxicosis. Lancet 1986; 14:1369-1372.
7. Leech NJ, Dayan CM. Controversies in the management of Graves' disease. Clin Endocrinol 1998; 49:273-280.
8. Reinhardt MJ, Brink I, Joe AY, Mallek D, Ezziddin S, Palmedo H. Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome. Eur J Nucl Med 2002; 29:1118-1124.
9. Zanzonico PB. Internal radionuclide radiation dosimetry: a review of basic concepts and recent developments. J Nucl Med 2000; 41:297-308.
10. Marinelli LD, Quimby EH, Hyne GJ. Dosage determination radioactive isotopes. Am J Roentgenol 1948; 59:260-281.
11. Bockisch A, Jamitzky T, Derwanz R, Biersack HJ. Optimized dose planning of radioiodine therapy of benign thyroidal diseases. J Nucl Med 1993; 34:1632-1638.
12. Cristy M, Eckerman K. Specific Absorbed Fractions of Energy at Various Ages from Internal Photons Sources. ORNL/TM-8381 V1-V7. Oak Ridge, Tennessee: Oak Ridge National Laboratory; 1987.
13. Stabin MG, Watson E, Cristy M, Ryman J, Eckerman K, Davis J, et al. Mathematical Models of the Adult Female at Various Stages of Pregnancy. ORNL/TM-12907. Oak Ridge, Tennessee: Oak Ridge National Laboratory; 1995.
14. Stabin MG. MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996; 37:538-546.
15. Snyder WS, Ford MR, Warner GG. Estimates of Specific Absorbed Fractions for Photon Sources Uniformly Distributed in Various Organs of a Heterogeneous Phantom. MIRD Pamphlet No 5 (revised). New York: Society of Nuclear Medicine; 1978.
16. International Commission on Radiological Protection. Individual Monitoring for External Exposure of Workers. ICRP Publication 78. Oxford, UK: Pergamon Press; 1997.
17. Di Martino F, Traino AC, Brill AB, Stabin MG, Lazzeri M. A theoretical model for prescription of the patient-specific therapeutic activity for radioiodine therapy of Graves' disease. Phys Med Biol 2002; 47:1493-1499.
18. Matheoud R, Canzi C, Reschini E, Zito F, Voltini F, Gerundini P. Tissue-specific dosimetry for radioiodine therapy of the autonomous thyroid nodule. Med Phys 2003; 30:791-798.
19. Murakami Y, Takamatsu J, Sakane S, Kuma K, Ohsawa N. Changes in thyroid volume in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome. J Clin Endocrinol Metab 1996; 81:3257-3260.
20. Nygaard B, Hegedüs L, Gervil M, Hjalgrim M, Hansen BM, Soe-Jensen P, Hansen JM, et al. Influence of compensated radioiodine therapy on thyroid volume and incidence of hypothyroidism in Graves' disease. J Intern Med 1995; 238:491-497.
21. Peters H, Fischer C, Bogner U, Reiners C, Schleusener H. Reduction in thyroid volume after radioiodine therapy of Graves' hyperthyroidism: results from a prospective, randomized, multicentre study. Eur J Clin Invest 1996; 26:59-63.
22. Traino AC, Di Martino F, Lazzeri M, Stabin MG. Influence of thyroid volume reduction on calculated dose in radioiodine therapy of Graves' hyperthyroidism. Phys Med Biol 2000; 45:121-129.
23. 131I therapy of Graves' disease. Radiat Prot Dosim 2001; 95:117-124.
24. Beierwaltes WH. The treatment of hyperthyroidism with iodine-131. Semin Nucl Med 1978; 8:95-103.
25. Doi SA, Loutfi I, Al-Shoumer KA. A mathematical model of optimized radioiodine-131 therapy of Graves' hyperthyroidism. BMC Nucl Med 2001; 1:1-10.
26. Commission of the European Communities. Health Protection of Individuals Against the Dangers of Ionising Radiation in Relation to Medical Exposure. Council Directive 97/43, Brussels, 1997. Available from:
27. Cormack J, Shearer J. Calculation of radiation exposures from patients to whom radioactive materials have been administered. Phys Med Biol 1998; 46:501-516.
28. Schlögl S, Werner E, Lassmann M, Terekova J, Muffert S, Seybold S, Reiners Chr, et al. The use of three-dimensional ultrasound for thyroid volumetry. Thyroid 2001; 11:569-574.
29. Van Isselt JW, de Klerk JMH, Van Rijk PP, Van Gils AP, Polman LJ, Kamphuis C, et al. Comparison of methods for thyroid volume estimation in patients with Graves' disease. Eur J Nucl Med 2003; 30:525-531.
30. Jönsson H, Mattsson S. Excess radiation absorbed dose from non-optimised radioiodine treatment of hyperthyroidism. Radiat Prot Dosim 2004; 108:107-114.